Evaluating SARS-CoV-2 Saliva and Dried Blood Spot Surveillance Strategies in a Congregate Population
- PMID: 37579513
- PMCID: PMC10461675
- DOI: 10.3201/eid2909.230417
Evaluating SARS-CoV-2 Saliva and Dried Blood Spot Surveillance Strategies in a Congregate Population
Abstract
The optimal approach to COVID-19 surveillance in congregate populations remains unclear. Our study at the US Naval Academy in Annapolis, Maryland, USA, assessed the concordance of antibody prevalence in longitudinally collected dried blood spots and saliva in a setting of frequent PCR-based testing. Our findings highlight the utility of salivary-based surveillance.
Keywords: COVID-19; SARS-CoV-2; congregate population; coronavirus disease; dried blood spot; respiratory infections; saliva; severe acute respiratory syndrome coronavirus 2; strategies; surveillance; vaccine-preventable diseases; viruses; zoonoses.
Figures
References
-
- Diepstra K, Bullington BW, Premkumar L, Shook-Sa BE, Jones C, Pettifor A. SARS-CoV-2 seroprevalence: demographic and behavioral factors associated with seropositivity among college students in a university setting. J Adolesc Health. 2022;71:559–69. 10.1016/j.jadohealth.2022.06.015 - DOI - PMC - PubMed
-
- Kimball A, Hatfield KM, Arons M, James A, Taylor J, Spicer K, et al.; Public Health – Seattle & King County; CDC COVID-19 Investigation Team. Public Health–Seattle & King County; CDC COVID-19 Investigation Team. Asymptomatic and presymptomatic SARS-CoV-2 infections in residents of a long-term care skilled nursing facility—King County, Washington, March 2020. MMWR Morb Mortal Wkly Rep. 2020;69:377–81. 10.15585/mmwr.mm6913e1 - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
